D.E. Shaw & Co’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.3M Sell
20,700
-186,300
-90% -$13M ﹤0.01% 3248
2025
Q4
$13.7M Buy
+207,000
New +$13.4M 0.01% 1488
2025
Q3
Sell
-100,000
Closed -$8.73M 4661
2025
Q2
$8.73M Sell
100,000
-12,500
-11% -$980K 0.01% 1600
2025
Q1
$7.68M Buy
+112,500
New +$9.18M 0.01% 1589
2024
Q3
Sell
-37,200
Closed -$4.22M 4635
2024
Q2
$4.22M Sell
37,200
-3,700
-9% -$468K 0.01% 1989
2024
Q1
$5.67M Sell
40,900
-42,600
-51% -$5.35M 0.01% 1799
2023
Q4
$10.4M Buy
83,500
+75,000
+882% +$7.66M 0.02% 1335
2023
Q3
$793K Buy
8,500
+6,000
+240% +$676K ﹤0.01% 3197
2023
Q2
$321K Hold
2,500
﹤0.01% 3579
2023
Q1
$290K Sell
2,500
-171,200
-99% -$19.2M ﹤0.01% 3763
2022
Q4
$19.7M Sell
173,700
-146,000
-46% -$16M 0.03% 938
2022
Q3
$25.7M Sell
319,700
-57,900
-15% -$4.9M 0.05% 707
2022
Q2
$28.1M Buy
377,600
+96,400
+34% +$8.8M 0.05% 670
2022
Q1
$36M Sell
281,200
-228,800
-45% -$25M 0.05% 650
2021
Q4
$68.5M Sell
510,000
-86,400
-14% -$12.4M 0.08% 412
2021
Q3
$81.5M Buy
596,400
+40,400
+7% +$5.09M 0.1% 324
2021
Q2
$59.4M Buy
556,000
+168,800
+44% +$16.2M 0.07% 457
2021
Q1
$34.8M Sell
387,200
-44,800
-10% -$4.21M 0.04% 652
2020
Q4
$39.9M Sell
432,000
-34,000
-7% -$3.04M 0.05% 598
2020
Q3
$48M Buy
466,000
+210,400
+82% +$22M 0.06% 432
2020
Q2
$25.9M Buy
255,600
+72,000
+39% +$6.44M 0.04% 648
2020
Q1
$12.4M Buy
183,600
+163,600
+818% +$10.2M 0.02% 880
2019
Q4
$1.09M Hold
20,000
﹤0.01% 2916
2019
Q3
$746K Hold
20,000
﹤0.01% 3000
2019
Q2
$749K Hold
20,000
﹤0.01% 2846
2019
Q1
$596K Hold
20,000
﹤0.01% 2904
2018
Q4
$599K Buy
+20,000
New +$634K ﹤0.01% 2988
2017
Q4
Sell
-40,000
Closed -$489K 3608
2017
Q3
$489K Buy
+40,000
New +$707K ﹤0.01% 2920
2015
Q4
Sell
-71,200
Closed -$1.53M 3844
2015
Q3
$1.53M Hold
71,200
﹤0.01% 2292
2015
Q2
$1.42M Buy
+71,200
New +$1.25M ﹤0.01% 2448
2014
Q2
Sell
-40,800
Closed -$422K 4288
2014
Q1
$422K Hold
40,800
﹤0.01% 3725
2013
Q4
$361K Buy
+40,800
New +$323K ﹤0.01% 3943

Other funds holding DXCM